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Abstract Limb girdle muscular dystrophy type 2A is linked to
a skeletal muscle-speci¢c calpain isoform known as p94. Isola-
tion of the intact 94-kDa enzyme has been di⁄cult to achieve
due to its rapid autolysis, and uncertainty has arisen over its
Ca2+-dependence for activity. We have expressed a C-termi-
nally truncated form of the enzyme that comprises the protease
core (domains I and II) along with its insertion sequence, IS1,
and N-terminal leader sequence, NS. This 47-kDa p94I-II mini-
calpain was stable during puri¢cation. In the presence of Ca2+,
p94I-II cleaved itself within the NS and IS1 sequences. Map-
ping of the autolysis sites showed that NS and IS1 have the
potential to be removed without damage to the protease core.
Ca2+-dependent autolysis must be an intramolecular event be-
cause the inactive p94I-II C129S mutant was not cleaved by
incubation with wild-type p94I-II. In addition, the rate of autol-
ysis of p94I-II was independent of the concentration of the
enzyme.
1 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The calpains are cytosolic Ca2þ-dependent cysteine pro-
teases that have been implicated in a wide variety of intra-
cellular processes linked to Ca2þ signaling [1]. Through lim-
ited proteolysis of their substrates calpains play an important
role in signal transduction [2], cell cycle regulation [3], cell
di¡erentiation [4] and apoptosis [5]. Calpains have been found
in organisms ranging from mammals to bacteria, and genome
sequencing has shown that multiple isoforms are present in
Drosophila melanogaster, Caenorhabditis elegans and humans
[6].
The two ubiquitous mammalian calpains, W- and m-calpain,
each form a heterodimer of the large subunit (products of the
capn1 and capn2 genes, respectively) with a common 30-kDa
regulatory subunit (product of the capn4 gene) [2,7]. The crys-
tal structure of m-calpain in the absence of Ca2þ was recently
solved, and it rede¢ned the presence and organisation of four
distinct domains in the large subunit [8,9]. Domains I and II
together comprise a papain-like cysteine protease core. Do-
main III is structurally similar to a Ca2þ and phospholipid-
binding C2 domain, and domain IV, which is similar to do-
main VI of the regulatory subunit, has a penta-EF-hand struc-
ture.
The ¢rst of the tissue-speci¢c calpains, calpain 3 (CAPN3
or p94), was described in skeletal muscle [10] and was genet-
ically linked to limb girdle muscular dystrophy type 2A
(LGMD2A) [11]. Accordingly, mutations in the gene (capn3)
that encodes p94 have been found in patients su¡ering from
LGMD2A and result in a decrease or loss of enzymatic ac-
tivity [11^13], suggesting the importance of p94 in normal
muscle physiology. p94 has 54% amino acid sequence identity
to the W-calpain large subunit, and is thought to have the
same domain structure but without a requirement for the
30-kDa regulatory subunit [10,14]. The larger size of p94 is
due to three extra sequences, an N-terminal extension (NS),
and two insertion sequences: IS1 in domain II, and IS2 be-
tween domains III and IV. These sequences are not found in
the other calpain isoforms nor do they have obvious homo-
logues in the current protein database. They presumably con-
tribute to p94’s unique properties and physiological function.
For example, IS2 contains a lysine-rich putative nuclear local-
isation signal and p94 has been found in both the nucleus and
the cytoplasm [15]. As well, p94 binds to connectin/titin
through its IS2 region, although the NS and IS1 regions
may also contribute to this interaction [13,16].
Attempts to analyse p94 at the protein level have been
stymied due to the rapid autolysis of p94 in vitro. It has a
half-life of less than 20 min, and typical calpain inhibitors
such as the W- and m-calpain endogenous inhibitor calpasta-
tin, and the cysteine protease inhibitors E-64 and leupeptin,
fail to inhibit the autolytic activity of p94 [15]. There is even
disagreement about p94’s dependence on Ca2þ for activity. It
was previously shown that p94 rapidly autolysed in the pres-
ence of EDTA [17], while another report indicated that p94
was stable in EGTA [18]. The presence of a Ca2þ-binding
penta-EF-hand domain IV and the postulated Ca2þ-binding
C2-like DIII [19] in p94 suggests that p94 binds Ca2þ. Indeed,
Ca2þ binding to p94 was directly demonstrated by Branca et
al. [18], using a gel overlay method. However, in W-calpain
these Ca2þ-binding domains are not directly involved in re-
alignment of the active site for catalysis. This is the role of
two novel Ca2þ-binding sites in protease domains I and II
[20]. Sequence alignments indicate that the key Ca2þ-liganding
amino acids of these new sites are conserved in the protease
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core of p94 and should be functional. In light of these results
we have expressed and characterised this region of p94 (do-
mains I and II, p94I-II) in an attempt to clarify the Ca2þ-
dependence of p94. We report here that p94I-II is a Ca2þ-
dependent cysteine protease with many properties similar to
those of the full-length enzyme, and that it undergoes intra-
molecular cleavage within its N-terminal NS and IS1 insertion
sequences close to the junctions with domains I and II.
2. Materials and methods
2.1. Cloning of the protease region of p94 and site-directed mutagenesis
The cDNA encoding the protease region of p94 was obtained by
polymerase chain reaction ampli¢cation of reverse transcripts (RT-
PCR) of total RNA from human skeletal muscle (Stratagene) using
reverse transcriptase (Gibco) and Pwo polymerase (Roche). The con-
struct starts at the N terminus of p94 and extends to the end of
domain II (residue 419). The cDNA was cloned into the NdeI and
XhoI sites of the pET24d expression vector (Novagen), which incor-
porates a C-terminal histidine tag onto the construct. To make an
inactive mutant of p94I-II, the active site Cys (C129) was replaced
by Ser using the PCR method and 5P-GCGAGAAACCAGC-
TGTCCCCTAGCTC-3P as the mutagenic primer [21].
2.2. Protein expression and puri¢cation
Plasmid encoding active or inactive (C129S) p94I-II was transfected
into Escherichia coli BL21(DE3) (Novagen) by electroporation. LB
media (100 ml) was inoculated from a single colony and grown over-
night at 37‡C under kanamycin selection before seeding 4 L of LB/
kanamycin broth, which was then grown to an OD600 of 0.8 to 1.0 at
20‡C. Protein expression was induced with 0.4 mM IPTG for 5 h. The
cells were collected, resuspended in 50 ml of lysis bu¡er (25 mM Tris^
HCl, 5 mM EDTA, 1 mM L-mercaptoethanol (pH 7.8)), and lysed
through sonication. The soluble fraction was applied to 200 ml of
DEAE-Sephacel resin. Protein was eluted with a 0^1 M NaCl salt
gradient in lysis bu¡er, and fractions containing p94I-II, as deter-
mined by the presence of a prominent band at 47 kDa on SDS^
PAGE, were pooled and applied to a 10-ml Ni2þ-chelating agarose
column (Qiagen). The column was washed with 20 mM imidazole (pH
7.6), and batch-eluted with 250 mM imidazole (pH 7.6). The pooled
fractions containing p94I-II were dialysed overnight into lysis bu¡er
to remove imidazole. p94I-II was further puri¢ed by Q-Sepharose
FPLC. Bound p94I-II was eluted by a 0^1 M NaCl gradient in lysis
bu¡er. The absorbance pro¢le was measured at 280 nm and selected
fractions were analysed by SDS^PAGE. The puri¢ed protein was
concentrated in a Biomax 30K concentrator (Millipore), diluted in
10 mM Tris^HCl, 10 mM DTT and 5 mM EDTA (pH 7.8) to a ¢nal
protein concentration of 20 mg/ml, aliquotted into 20 Wl volumes, and
£ash frozen in liquid N2 for storage. The inactive p94I-II C129S mu-
tant was puri¢ed in a similar manner.
2.3. Expression and puri¢cation of 35S-L-Cys-labelled active or
inactive p94I-II
E. coli transformed with plasmid encoding wild-type or inactive
C129S p94I-II were grown in M9 salts minimal media (50 mM
Na2HPO4, 20 mM KH2PO4, 8 mM NaCl, 18 mM NH4Cl, 2 mM
MgSO4, 0.1 mM CaCl2, 1 mM thiamine) at 30‡C, under kanamycin
selection, to an OD600 of 1.0. Radio-labelled protein expression com-
menced with the addition of 0.4 mM IPTG and 500 WCi of 35S-L-Cys.
The protein was puri¢ed as previously described.
2.4. Enzyme activity
Autoproteolytic activity was measured by incubating recombinant
p94I-II (200 Wg) in 10 mM Tris^HCl (pH 7.6), 10 mM DTT with 10
mM CaCl2 at 20‡C in a ¢nal volume of 500 Wl. Aliquots were re-
moved at the times indicated, and the reaction stopped with SDS
sample bu¡er (NEB). The digestion products were analysed by 10%
SDS^PAGE gel. A control assay consisting of p94I-II incubated with
10 mM EDTA (pH 8.0) in place of CaCl2 was performed in the same
fashion.
2.5. Discrimination between inter- and intramolecular autolysis
Unlabelled inactive mutant p94I-II (C129S) (4 WM ¢nal concentra-
tion) was mixed in a 2:1 molar ratio with 35S-labelled active p94I-II
(2 WM ¢nal concentration). The constructs were incubated in 10 mM
Tris^HCl (pH 7.6), 10 mM DTT, and 10 mM CaCl2 at 37‡C for 24 h.
Aliquots were removed at various time points into SDS sample bu¡er,
and digestion products were visualised by 10% SDS^PAGE and auto-
radiography. In other experiments, unlabelled active and labelled in-
active preparations of p94I-II were mixed in the same 2:1 molar ratio,
incubated and analysed as above.
2.6. The rate of p94I-II autolysis as a function of concentration
p94I-II (5 Wg) was allowed to autolyse at room temperature for 4 h
in di¡erent volumes (8, 40, 200 and 1000 Wl) of 10 mM NH4HCO3, 10
mM DTT and 1 mM CaCl2. The reaction was stopped by the addition
of 5 mM EDTA, pH 8.0. The solutions were frozen and lyophilised
overnight. The resulting dry residue was resuspended in SDS sample
bu¡er (30 Wl) and the autolysis fragments visualised by SDS^PAGE.
Two control assays were performed, one where the sample (8 Wl vol-
ume) was not lyophilised, and another where 10 mM Tris^HCl (pH
7.6) replaced 10 mM NH4HCO3 (pH 8.0).
2.7. Peptide sequencing
The fragments generated from p94I-II autolysis in the presence of
Ca2þ were separated by SDS^PAGE on a Tris^Tricine 10% polyac-
rylamide gel, and electroblotted onto PVDF membranes of 0.1-Wm-
pore size (Millipore) at 0.5 A for 1 h. Cleavage points were deter-
mined by automated N-terminal Edman degradation sequencing of
major bands using a Hewlett Packard G1005A protein solid-phase
sequencer with on-line PTH analysis.
3. Results
3.1. Expression and puri¢cation of recombinant p94I-II
The protease core of p94 was relatively soluble during ex-
pression, with approximately half of the expressed protein
appearing in the supernatant fraction of the lysed E. coli.
The soluble p94I-II fraction was stable throughout its puri¢-
cation and concentration. It co-eluted with a variety of other
E. coli proteins from the DEAE resin, but was s 90% pure
after batch-elution from the Ni2þ-chelating agarose column
(not shown). It eluted from Q-Sepharose FPLC at 0.2 M
NaCl, and was s 95% pure as indicated by SDS^PAGE
(Fig. 1C, lane 0 m). A yield of 15 mg was obtained from a
4-l culture.
3.2. p94I-II autolysis is Ca2+-dependent
When p94I-II was incubated in the presence of 10 mM
CaCl2 the 47-kDa protein was cleaved internally. Upon
SDS^PAGE analysis, two major fragments of approximately
30 and 15 kDa (bands 1a and 1b in Fig. 1B) were seen. Small
quantities of these fragments appeared immediately after the
addition of CaCl2 (even in the time it took to withdraw the
zero time sample) and increased in intensity over time. The
half-life of p94I-II was approximately 20 min as judged by the
disappearance of half of the 47-kDa starting material at this
time point, and very little p94I-II remained intact after 4 h.
Around this time, additional cleavage products (bands 2a and
2b in Fig. 1B) began to accumulate and were the dominant
products after 24 to 48 h. No breakdown products were ob-
served over the same time frame when p94I-II was incubated
with chelating agent (10 mM EDTA) in place of 10 mM
CaCl2 (Fig. 1C).
The N-terminal sequences of the initial breakdown products
1a and 1b, were AEPRS and GTSPS, respectively (Table 1).
These correspond to autolysis sites near the N-terminal ends
of the NS and IS1 insertion sequences after amino acids 14
and 274, respectively (Fig. 1A). The later cleavage products,
2a and 2b, began with the sequences AIISR and TIIPV, re-
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spectively. These correspond to autolysis sites near the C-ter-
minal ends of the NS and IS1 insertion sequences after amino
acids 44 and 315, respectively. The cleavage sequences are
distinct. All four sequences have a Pro and/or Gly near the
cleavage point, and there is a preference for a small residue
(Ala, Gly or Thr) at the P1P position. Three of them have a
Thr at the P2 position, and the fourth has a Tyr.
3.3. p94I-II does not proteolyse inactive p94I-II C129S
Cys 129 is the catalytically active residue in the active site
and corresponds to Cys 105 in m-calpain and Cys 115 in
W-calpain. When this residue was converted to Ser, p94I-II
C129S did not produce cleavage products and was inde¢nitely
stable in the presence of Ca2þ (not shown). This indicates that
the p94I-II breakdown products (Fig. 1B) were produced by
autolysis and not by trace amounts of a metal ion-dependent
protease contaminant.
When active and inactive p94I-II were combined in di¡erent
ratios the autolysis was incomplete as judged by SDS^PAGE.
For example, when 10% of the mixture was p94I-II, only
V10% was digested, and 90% remained as the 47-kDa start-
ing material (not shown). This was consistent with a failure of
the active enzyme to cleave the inactive C129S mutant in an
intermolecular process. To con¢rm and illustrate this result,
the active enzyme was uniformly labelled with 35S-Cys and
incubated with unlabelled C129S mutant in a 1:2 molar ratio
(Fig. 2A). After 24 h, approximately one third of the starting
material had been broken down to the 30-kDa and sub-15-
kDa digestion products as judged by Coomassie blue staining,
and two-thirds remained undegraded (Fig. 2B). The autora-
diograph of this gel showed that all of the labelled protein was
broken down by the 5-h time point (Fig. 2C).
In the converse experiment, where radio-labelled inactive
p94I-II was incubated with the unlabelled active construct in
the same manner (Fig. 2D), the starting amount of inactive
protein (one-third of the total loaded onto the gel) remained
unchanged as determined by the autoradiograph (Fig. 2F).
The autolysis products are clearly visible on the SDS^PAGE
by Coomassie blue staining, but did not appear on the auto-
radiograph. This indicates that they belong to the unlabelled
active protein and not to the labelled inactive p94 I-II (Fig.
2E,F).
3.4. p94I-II autolysis is concentration independent
Intramolecular reactions have been reported to follow zero
order kinetic rate law; that is, their reaction rates are inde-
pendent of the concentration of the reactant [22]. If p94I-II
cleavage is an intramolecular reaction, then the rate of autol-
ysis should be independent of p94I-II concentration. When
p94I-II was incubated in 1 mM CaCl2 over a 125-fold con-
centration range (from 0.005 mg/ml to 0.625 mg/ml) there was
no change in the ratio of the products (30 and 15 kDa) and
reactant (47 kDa) after 4 h, as judged by the relative intensity
of staining of the protein bands (Fig. 3). Recovery of the most
Fig. 1. Ca2þ-dependence of p94I-II autolysis. A: Map of p94I-II showing its domain structure and the location of initial (1a, 1b) and subse-
quent (2a, 2b) autolytic cleavage sites. B: SDS^PAGE analysis of p94I-II autolysis. Lanes are marked with the time of incubation, with m re-
ferring to minutes. The initial 30-kDa and 15-kDa cleavage products are indicated in the 2-h time point by arrows 1a and 1b, respectively. The
cleavage products produced later in the autolysis are marked in the 48-h time point by arrows 2a and 2b. N-terminal Edman degradation se-
quencing determined the cleavage points to be within the unique insertion sequences of p94I-II (A and Table 1). M represents molecular weight
markers. C: SDS^PAGE analysis of p94I-II incubated in the presence of excess EDTA.
Table 1
Autolytic cleavage sites in p94I-II
p94I-II fragment P5 P4 P3 P2 P1 P1P P2P P3P P4P P5P
1a A P R T A A E P R S
1b T N M T Y G T S P S
2a S G I Y S A I I S R
2b E R P T R T I I P V
PP positions were determined by N-terminal Edman degradation se-
quencing of cleavage products generated after 2 h (1a, 1b) and 48 h
(2a, 2b) of autolysis. The locations of 1a, 1b, 2a, 2b in p94I-II are
indicated in Fig. 1A. Pro and Gly are shown in bold.
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dilute digest after lyophilisation was incomplete, but there was
equivalent loss of all three major bands. Again, there was no
digestion in the presence of excess EDTA. The change of
bu¡er from Tris^HCl (pH 7.6) to NH4HCO3 (pH 8.0) did
not change the reaction rate or products, and neither did
lyophilisation.
4. Discussion
Expression of the protease core of p94 (p94I-II) has facili-
tated characterisation of some of its biochemical properties
that are relevant to the whole enzyme. The uncertainty about
the Ca2þ-dependence of p94 has been exacerbated by the dif-
Fig. 2. p94I-II cannot proteolyse the inactive mutant p94I-II C129S. A: SDS^PAGE analysis of the proteolysis of non-labelled inactive mutant
p94I-II C129S by labelled p94I-II C129 in 10 mM CaCl2 at a 1:2 molar ratio of active: inactive enzyme. M represents molecular weight
markers. B: An autoradiograph of the gel, developed for 7 days. C: Model showing radio-labelled p94I-II (striped, with NS and IS1 regions
shown in dark grey) undergoing autolysis of the NS and IS1 in the presence of Ca2þ while the unlabelled inactive mutant (S129; domain I and
II in medium and light grey, respectively) remains uncleaved. D: Reversal of A, where the inactive mutant S129 was radio-labelled and incuba-
ted with the active construct in the same manner. E: An autoradiograph of the SDS^PAGE gel from D. F: Model showing the radio-labelled
inactive p94I-II C129S (striped) is not cleaved at its NS or IS1 regions during incubation with unlabelled active p94I-II (grey) in the presence
of Ca2þ.
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¢culty in expressing the whole enzyme in a heterologous sys-
tem, and by its rapid autolysis during puri¢cation
[15,17,18,23]. p94I-II is stable in the presence of EDTA, and
this has enabled us to assay its Ca2þ-dependence for autolytic
activity. Our results clearly show that the protease core of p94
autolyses in the presence of Ca2þ, and that the reaction is
blocked by an excess of the divalent cation chelator, EDTA.
This is consistent with the discovery of two novel Ca2þ-bind-
ing sites in the protease core of W-calpain, one in domain I
and the other in domain II, that appear to act cooperatively in
aligning the active site of the enzyme [20]. Sequence compar-
isons of several calpain protease core regions indicate that the
residues that use their side chains to coordinate Ca2þ ions in
WI-II are well conserved. They (D120, E199, E353, D360 and
D382) are present in p94 along with Arg118 and Glu384 that
form the double salt-bridge pair, which is thought to be a key
element of the cooperativity mechanism. Our observation that
p94I-II requires Ca2þ for autolytic activity con¢rms this pre-
diction and is in line with the observation of Branca et al. that
p94 activity is dependent on Ca2þ and can be abolished by
chelating agents [18].
That autoproteolysis of p94I-II is an intramolecular reac-
tion is based on two lines of evidence: p94I-II seems com-
pletely unable to cut an active site mutant (C129S) in an
intermolecular reaction, and the autolysis of the initial cleav-
age points (1a and 1b) is independent of concentration. Con-
centration dependence of the rate of autolysis has been used
previously in attempts to di¡erentiate between inter- and in-
tramolecular autolysis for the ubiquitous calpains [22,24,
26,27]. No de¢nitive conclusions have been made regarding
m- and W-calpain autolysis. Some reports suggest that only
intramolecular autolysis occurs [22,26,28], other con£icting
results indicate that the autolysis is intermolecular [29], or
includes both types of reactions [30]. Here, we have used a
novel combination of site-speci¢c mutation and radio-label-
ling to address the autolysis issue in p94. The evidence seems
unequivocal that p94I-II autolysis at the ¢rst cleavage points
follows a Ca2þ- dependent intramolecular reaction pathway
with no apparent intermolecular autolysis. We see no evidence
that autolysis at the later cleavage points (2a and 2b) is inter-
molecular but cannot rule out the possibility. The inability of
the active mutant to cleave inactive p94I-II even after 24 h
suggests that this second autolysis event is also intramolecu-
lar, or may be dependent upon initial intramolecular cleavage
at the ¢rst autolytic site.
Of the four major autolytic sites detected in p94I-II, two
reside in NS and two in IS1. Fragment 1b, the ¢rst major
cleavage product (in IS1) has the same N-terminal sequence
as the 60-kDa autolytic cleavage product of rabbit p94, which
stretches from IS1 to the C terminus [17]. Additional clea-
vages within IS1 were noted by Kinbara et al. [17] for rabbit
and rat p94, but none of them corresponded to the late cleav-
age product of p94I-II (2b). Federici et al. [23] reported cleav-
age of recombinant p94 in NS after residue 30, which is in-
ternal to the earliest cleavage site in p94I-II [23]. (Federici et
al. [23] also reported cleavage of recombinant p94 just inside
domain III after residue 412, which would generate a natural
product not unlike the p94I-II studied here). When these
cleavage sequences are compared, little in the way of a con-
sensus emerges. This is consistent with the general observa-
tions about calpain substrate speci¢city in that the heterodi-
meric calpains m- and W- cleave £exible regions with relatively
little preference for a speci¢c amino acid sequence [1,2,7]. The
NS and IS1 insertion sequences are quite rich in Pro and Gly
and are possibly less well-structured than the other regions
of the enzyme. In addition, a model of p94 based on the
m-calpain crystal structure displays the unique insertion se-
quences as protruding from the globular protein, thus making
them susceptible to proteolysis [25].
It is signi¢cant that the autolysis sites in p94I-II are con-
¢ned to the NS and IS1 regions and that after extensive cleav-
age both segments are cut near each end without any damage
to the underlying domains I and II. Autolysis at both the
N- and C-terminal ends of the IS1 region suggests that IS1
may be an internal peptide that needs to be removed in re-
sponse to Ca2þ signaling. In e¡ect, IS1 may be an internal
pro-segment. In many of the cysteine proteases activation in-
volves the autolytic removal of a pro-peptide to generate the
active protease [31]. A deletion mutant of p94 from which IS1
was removed had increased stability comparable to m-calpain
[32]. Conversely, addition of IS1 to Lp82 (the splicing variant
of p94 that does not contain IS1 or IS2) created an unstable
enzyme that lacked proteolytic activity on exogenous sub-
strates [33]. This indicates that IS1 is at least partially respon-
sible for the instability of the enzyme. IS1 might provide an
additional regulatory step in p94 activation whereby the IS1
region remains in the active site, preventing substrate binding
for proteolysis until its release by autolysis.
Once again the removal of extraneous domains from a cal-
pain to form a ‘mini-calpain’ [20] has greatly facilitated its
characterisation. In conclusion, we have unequivocally dem-
onstrated that the protease core of the skeletal muscle-speci¢c
calpain, p94, is activated by Ca2þ and completely inhibited by
EDTA. Our results also suggest that NS and IS1 are £exible
in the presence of Ca2þ and are close enough to the active site
to be hydrolysed in an intramolecular reaction.
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